Healthcare provider profile · identity verified

Nitin Gaikwad, M.D.

Internal Medicine · GREENVILLE, SC · NPI 1457311433

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	567	78
Amlodipine Besylate	Amlodipine Besylate	280	112
Tramadol Hcl	Tramadol Hcl	243	67
Atorvastatin Calcium	Atorvastatin Calcium	242	97
Zolpidem Tartrate	Zolpidem Tartrate	242	47
Rosuvastatin Calcium	Rosuvastatin Calcium	231	94
Levothyroxine Sodium	Levothyroxine Sodium	213	75
Alprazolam	Alprazolam	207	38
Gabapentin	Gabapentin	161	65
Albuterol Sulfate Hfa	Albuterol Sulfate	158	70
Lisinopril	Lisinopril	146	60
Fluticasone Propionate	Fluticasone Propionate	139	65
Ozempic	Semaglutide	135	30
Lorazepam	Lorazepam	129	32
Pantoprazole Sodium	Pantoprazole Sodium	129	55
Omeprazole	Omeprazole	126	53
Metformin Hcl	Metformin Hcl	125	50
Losartan Potassium	Losartan Potassium	122	53
Azithromycin	Azithromycin	105	83
Tizanidine Hcl	Tizanidine Hcl	104	50
Furosemide	Furosemide	99	41
Meloxicam	Meloxicam	96	52
Metoprolol Succinate	Metoprolol Succinate	96	38
Tamsulosin Hcl	Tamsulosin Hcl	92	29
Jardiance	Empagliflozin	91	36
Prednisone	Prednisone	82	62
Metoprolol Tartrate	Metoprolol Tartrate	81	38
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	26
Alendronate Sodium	Alendronate Sodium	73	24
Clopidogrel	Clopidogrel Bisulfate	73	35
Simvastatin	Simvastatin	72	24
Eliquis	Apixaban	64	29
Famotidine	Famotidine	64	27
Ondansetron Hcl	Ondansetron Hcl	63	30
Hydrochlorothiazide	Hydrochlorothiazide	61	29
Carvedilol	Carvedilol	57	25
Clonazepam	Clonazepam	56	13
Montelukast Sodium	Montelukast Sodium	55	26
Allopurinol	Allopurinol	54	19
Baclofen	Baclofen	53	13
Diclofenac Sodium	Diclofenac Sodium	51	21
Potassium Chloride	Potassium Chloride	51	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	16
Pravastatin Sodium	Pravastatin Sodium	48	19
Sertraline Hcl	Sertraline Hcl	47	19
Glipizide Er	Glipizide	45	16
Mounjaro	Tirzepatide	45	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	45	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	36
Farxiga	Dapagliflozin Propanediol	39	16
Escitalopram Oxalate	Escitalopram Oxalate	38	15
Meclizine Hcl	Meclizine Hcl	38	16
Doxycycline Hyclate	Doxycycline Hyclate	37	27
Metformin Hcl Er	Metformin Hcl	36	14
Citalopram Hbr	Citalopram Hydrobromide	35	17
Trazodone Hcl	Trazodone Hcl	34	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Finasteride	Finasteride	30	13
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Spironolactone	Spironolactone	27	12
Atenolol	Atenolol	26	11
Clonidine Hcl	Clonidine Hcl	26	14
Promethazine Hcl	Promethazine Hcl	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	13
Dicyclomine Hcl	Dicyclomine Hcl	25	12
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Fluconazole	Fluconazole	23	18
Hydroxyzine Hcl	Hydroxyzine Hcl	23	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	11
Temazepam	Temazepam	23	suppressed
Sucralfate	Sucralfate	22	11
Torsemide	Torsemide	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Linzess	Linaclotide	20	11
Ondansetron Odt	Ondansetron	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	12
Mometasone Furoate	Mometasone Furoate	19	suppressed
Glipizide	Glipizide	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Amoxicillin	Amoxicillin	17	14
Hydrocortisone	Hydrocortisone	17	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Diazepam	Diazepam	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Nitroglycerin	Nitroglycerin	16	11
Novolog Flexpen	Insulin Aspart	16	suppressed
Cefdinir	Cefdinir	15	14
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Colchicine	Colchicine	14	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Estradiol	Estradiol	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Desloratadine	Desloratadine	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error